Emerging Disease Issues and Fungal Pathogens Associated with HIV Infection

Emerging Infectious Diseases

Volumn 2, Issue 2, 1996, Pages 109-116

  Ampel, Neil M ^a,b,c  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIDS RELATED COMPLEX; ASPERGILLOSIS; BLASTOMYCOSIS; CANDIDIASIS; COCCIDIOIDOMYCOSIS; CRYPTOCOCCOSIS; HISTOPLASMOSIS; HUMAN; MYCOSIS; PATHOPHYSIOLOGY; REVIEW;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ASPERGILLOSIS; BLASTOMYCOSIS; CANDIDIASIS; COCCIDIOIDOMYCOSIS; CRYPTOCOCCOSIS; HISTOPLASMOSIS; HUMANS; MYCOSES;

EID: 0030115305     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0202.960205     Document Type: Article

References (50)

1. Sangeorzan JA, Bradley SF, He X, Zarins LT, et al. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med 1994; 97:339-46.
2. Powderly WG, Robinson K, Keath EJ. Molecular epidemiology of recurrent oral candidiasis in human immunodeficiency virus-positive patients: evidence for two patterns of recurrence. J Infect Dis 1993; 168:463-6.
3. Whelan WL, Kirsch DR, Kwon-Chung KJ, Wahl SM, et al. Candida albicans in patients with the acquired immunodeficiency syndrome: absence of a novel or hypervirulent strain. J Infect Dis 1990; 162:513-8.
4. Klein RS, Harris CA, Butkus Small C, Moll B, et al. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984; 311:354-8.
5. Imam N, Carpenter CC, Mayer KH, Fisher A, et al. Hierarchical pattern of mucosal Candida infections in HIV-seropositive women. Am J Med 1990; 89:142-6.
6. Stevens DA, Greene SI, Lang OS. Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex: randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily Arch Intern Med 1991; 151:2458-64.
7. Redding S, Smith J, Farinacci G, Rinaldi M, et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis 1994; 18:240-2
8. Rex JH, Pfaller MA, Rinaldi MG, Polack A, et al. Antifungal susceptibility testing. Clin Microbiol Rev 1993; 6:357-81.
9. Dismukes WE. Cryptococcal meningitis in patients with AIDS. J Infect Dis 1988; 157:624-8.
10. Levitz SM. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis 1991; 13:1163-9.
11. Varma A, Swinne D, Staib F, Bennett JE, et al. Diversity of DNA fingerprints in Cryptococcus neoformans. J Clin Microbiol 1995; 33:1807-14.
12. Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989; 321:793-9.
13. Powderly WG, Finkelstein D, Feinberg J, Frame P, et al. (NIAID AIDS Clinical Trials Group). A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. N Engl J Med 1995; 332:700-5.
14. Larsen RA, Leal MAE, Chan LS. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS: a randomized trial. Ann Intern Med 1990; 113:183-7.
15. Saag MS, Powderly WG, Cloud GA, Robinson P, et al. (NIAID Mycoses Study Group and the AIDS Clinical Trials Group). Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992; 326:83-9.
16. Bozzette SA, Larsen RA, Chiu J, Leal MAE, et al. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. N Engl J Med 1991; 324:580-4.
17. Powderly WG, Saag MS, Cloud GA, Robinson P, et al. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 326:793-9.
18. Chandenier J, Goma D, Moyen G, Samba-Lefebvre MC, et al. [African histoplasmosis due to Histoplasma capsulatum var. duboisii: relationship with AIDS in recent Congolese cases]. Sante 1995; 5:227-34.
19. Wheat LJ, Connolly-Stringfield PA, Baker RL, Curfman MF, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine [Baltimore] 1990; 69:361-74.
20. Wheat LJ, Slama TG, Zeckel ML. Histoplasmosis in the acquired immune deficiency syndrome. Am J Med 1985; 78:203-10.
21. Wheat LJ. Histoplasmosis in Indianapolis. Clin Infect Dis 1992; 14 (Suppl 1):S91-9.
22. Huang CT, McGarry T, Cooper S, Saunders R, et al. Disseminated histoplasmosis in the acquired immunodeficiency syndrome: report of five cases from a nonendemic area. Arch Intern Med 1987; 147:1181-4.
23. Salzman SH, Smith RL, Aranda CP. Histoplasmosis in patients at risk for the acquired immunodeficiency syndrome in a nonendemic setting. Chest 1988; 93:916-21.
24. Wheat J, Hafner R, Korzun AH, Limjoco MT, et al. (AIDS Clinical Trials Group). Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Med 1995; 98:336-42.
25. McKinsey DS, Gupta MR, Riddler SA, Driks MR, et al. Long-term amphotericin B therapy for disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989; 111:655-9.
26. Wheat J, Hafner R, Wulfsohn M, Spencer P, et al. (NIAID Clinical Trials and Mycoses Study Group Collaborators). Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1993; 118:610-6.
27. Norris S, Wheat J, McKinsey D, Lancaster D, et al. Prevention of relapse of histoplasmosis with fluconazole in patients with the acquired immunodeficiency syndrome. Am J Med 1994; 96:504-8.
28. Wheat LJ, Connolly-Stringfield P, Blair R, Connolly K, et al. Effect of successful treatment with amphotericin B on Histoplasma capsulatum variety capsulatum polysaccharide antigen levels in patients with AIDS and histoplasmosis. Am J Med 1992; 92:153-60.
29. Jones JL, Fleming PL, Ciesielski CA, Hu DJ, et al. Coccidioidomycosis among persons with AIDS in the United States. J Infect Dis 1995; 171:961-6.
30. Ampel NM, Dols CL, Galgiani JN. Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area. Am J Med 1993; 94:235-40.
31. Einstein HE, Johnson RH. Coccidioidomycosis: new aspects of epidemiology and therapy. Clin Infect Dis 1993; 16:349-56.
32. CDC. Coccidioidomycosis following the Northridge Earthquake-California, 1994. MMWR 1994; 43:194-5.
33. Fish DG, Ampel NM, Galgiani JN, Dois CL, et al. Coccidiodiomycosis during human immunodeficiency virus infection: a review of 77 patients. Medicine [Baltimore] 1990; 69:384-91.
34. Mahaffey KW, Hippenmeyer CL, Mandel R, Ampel NM. Unrecognized coccidioidomycosis complicating Pneumocystis carinii pneumonia in patients infected with the human immunodeficiency virus and treated with corticosteroids: a report of two cases. Arch Intern Med 1993; 153:1496-8.
35. Antoniskis D, Larsen RA, Akil B, Rarick MU, et al. Seronegative disseminated coccidioidomycosis in patients with HIV infection. AIDS 1990; 4:691-3.
36. Arguinchona HL, Ampel NM, Dois CL, Galgiani JN, et al. Persistent coccidioidal seropositivity without clinical evidence of active coccidioidomycosis in patients infected with human immunodeficiency virus. Clin Infec Dis 1995; 20:1281-5.
37. Klein BS, Vergeront JM, Weeks RJ, Kumar UN, et al. Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin. N Engl J Med 1986; 314:529-34.
38. Pappas PG, Pottage JC, Powderly WG, Fraser VJ, et al. Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1992; 116:847-53.
39. Jaffe HW, Selik RM. Acquired immunodeficiency syndrome: is disseminated aspergillosis predictive of underlying cellular deficiency? [letter]. J Infect Dis 1984; 149:829.
40. Denning DW, Follansbee SE, Scolaro M, Norris S, et al. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med 1991; 324:654-62.
41. Singh N, Yu VL, Rihs JD. Invasive aspergillosis in AIDS. South Med J 1991; 84:822-6.
42. Klapholz A, Salomon N, Perlman DC, Talavera W. Aspergillosis in the acquired immunodeficiency syndrome. Chest 1991; 100:1614-8.
43. Lortholary O, Meyohas MC, Dupont B, Cadranel J, et al. (French Cooperative Study Group on Aspergillosis in AIDS). Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. Am J Med 1993; 95:177-87.
44. Miller WT, Jr., Sais GJ, Frank I, Gefter WB, et al. Pulmonary aspergillosis in patients with AIDS: clinical and radiographic correlations. Chest 1994; 105:37-44.
45. Denning DW, Lee JY, Hostetler JS, Pappas P, et al. NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am J Med 1994; 97:135-44.
46. Piehl MR, Kaplan RL, Haber MH. Disseminated penicilliosis in a patient with acquired immunodeficiency syndrome. Arch Pathol Lab Med 1988; 112:1262-4.
47. Supparatpinyo K, Sirisanthana T. Disseminated Penicillium marneffei infection diagnosed on examination of a peripheral blood smear of a patient with human immunodeficiency virus infection. Clin Infect Dis 1994; 18:246-7.
48. Supparatpinyo K, Khamwan C, Baosoung V, Nelson KE, et al. Disseminated Penicillium marneffei infection in southeast Asia. Lancet 1994; 344:110-3.
49. Perfect JR. Antifungal prophylaxis: to prevent or not? Am J Med 1993; 94:233-4.
50. Powderly WG. Prophylaxis for HIV-related infections: a work in progress. Ann Intern Med 1996; 124:342-4.